ALTSHULER DAVID (CIK 1550395) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-26). Recent activity: Buy VRTX (7,866 shares), Buy VRTX (3,328 shares), Sell VRTX (52 shares), Sell VRTX (3,231 shares), Sell VRTX (3,231 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Buy | 7,866 | $0 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Buy | 3,328 | $0 |
| 2025-05-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 52 | $22,084 |
| 2025-03-17 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 3,231 | $1.6M |
| 2025-03-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 3,231 | $1.6M |
| 2025-03-05 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 3,231 | $1.6M |
| 2025-02-28 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 5,954 | $2.9M |
| 2025-02-28 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 1,272 | $610,560 |
| 2025-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 3,971 | $1.9M |
| 2025-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 848 | $407,846 |
| 2025-02-24 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 1,111 | $533,280 |
| 2025-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 2,293 | $1.1M |
| 2025-02-14 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Buy | 5,324 | $0 |
| 2025-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 2,142 | $1.0M |
| 2025-02-06 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Buy | 12,314 | $0 |
| 2025-02-06 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Buy | 7,114 | $0 |
Source: SEC Form 4 filings · as of 2026-01-26